CardioGenics Inc Product Pipeline Analysis, 2018 Update [Report Updated: 10082018] Prices from USD $750

17:49 EDT 14 Oct 2018 | BioPortfolio Reports


CardioGenics Inc CardioGenics, a subsidiary of CardioGenics Holdings Inc is a medical device company that manufactures sensitive diagnostic test products to the invitro diagnostics market. The company's products include QL care analyzer, immunoassay tests, and paramagnetic beads, among others. Its QL care analyzer is a portable and automated point of care immune analyzer. CardioGenics provides immunoassay tests such as heart failure genomics risk test, heart failure risk stratification test, plasminogen activator inhibitor type1 test, and troponin I test. The company's immunoassay tests are used to detect cardiac markers. It also develops a novel proprietary and patentprotected method to control the delivery of compounds to a chemical reaction automating the trigger. CardioGenics is headquartered in Mississauga, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company CardioGenics Inc

The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research Development strategies

Develop marketentry and market expansion strategies

Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Original Article: CardioGenics Inc Product Pipeline Analysis, 2018 Update [Report Updated: 10082018] Prices from USD $750


More From BioPortfolio on "CardioGenics Inc Product Pipeline Analysis, 2018 Update [Report Updated: 10082018] Prices from USD $750"

Quick Search


Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...